{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:55Z","timestamp":1786989055904,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371044"],"award-info":[{"award-number":["82371044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.exer.2025.110273","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T02:37:37Z","timestamp":1738809457000},"page":"110273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Recombinant adeno-associated virus with anti-tumor necrosis factor-alpha in an experimental autoimmune uveitis model"],"prefix":"10.1016","volume":"253","author":[{"given":"Baiyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-4152","authenticated-orcid":false,"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.exer.2025.110273_bib1","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ophtha.2009.12.011","article-title":"Intravitreal adalimumab for refractory uveitis-related macular edema","volume":"117","author":"Androudi","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110273_bib2","article-title":"Gene therapy advances : a meta-analysis of AAV usage in clinical settings","volume":"8","author":"Au","year":"2021","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.exer.2025.110273_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0301-4738.114099","article-title":"Medical management of uveitis\u2014current trends","volume":"61","author":"Babu","year":"2013","journal-title":"Indian J. Ophthalmol."},{"issue":"20","key":"10.1016\/j.exer.2025.110273_bib4","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2025.110273_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors \u2013 implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib8","first-page":"15.6.1","article-title":"Experimental autoimmune uveoretinitis in the rat and mouse","volume":"53","author":"Caspi","year":"2003","journal-title":"Curr. Protoc. Im."},{"issue":"3","key":"10.1016\/j.exer.2025.110273_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.exer.2025.110273_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.10.4.3","article-title":"Inflammation in viral vector-mediated ocular gene therapy : a review and report from a workshop hosted by the foundation fighting blindness, 9\/2020","volume":"10","author":"Chan","year":"2021","journal-title":"Transla. Vision Sci Technol."},{"issue":"580","key":"10.1016\/j.exer.2025.110273_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3438","article-title":"Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses","volume":"13","author":"Chan","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.exer.2025.110273_bib12","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/ar3431","article-title":"Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-\u03b1 therapy","volume":"13","author":"Chen","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.exer.2025.110273_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/09273948.2012.726392","article-title":"Gene therapy for noninfectious uveitis","volume":"20","author":"Chu","year":"2012","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"2","key":"10.1016\/j.exer.2025.110273_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","article-title":"Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect","volume":"25","author":"Cideciyan","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56462-3","article-title":"AAV-mediated expression of HLA-G1\/5 reduces severity of experimental autoimmune uveitis","volume":"9","author":"Crabtree","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.exer.2025.110273_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270972","article-title":"Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy","volume":"17","author":"Crabtree","year":"2022","journal-title":"PLoS One"},{"issue":"189","key":"10.1016\/j.exer.2025.110273_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo\u2013directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.exer.2025.110273_bib18","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/mt.2009.181","article-title":"Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous","volume":"17","author":"Dalkara","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2025.110273_bib19","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2147\/OPTH.S47778","article-title":"Pharmacotherapy for uveitis : current management and emerging therapy","volume":"8","author":"Denniston","year":"2014","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002012","article-title":"Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis : results through 3 years from the SELECT-COMPARE study","volume":"8","author":"Fleischmann","year":"2022","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.exer.2011.04.012","article-title":"Correlation of optical coherence tomography with clinical and histopathological findings in experimental autoimmune uveoretinitis","volume":"93","author":"Gadjanski","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110273_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fceng.2022.830421","article-title":"Process improvement of adeno-associated virus production","volume":"4","author":"Guan","year":"2022","journal-title":"Front. Chem. Eng."},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/08820538.2017.1353811","article-title":"Complications of intravitreous injections in patients with diabetes","volume":"33","author":"Gupta","year":"2018","journal-title":"Semin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12985-024-02286-1","article-title":"Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma","volume":"21","author":"Hadi","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.exer.2025.110273_bib25","article-title":"Intravitreal adalimumab in active noninfectious uveitis : a pilot study","volume":"1\u20138","author":"Hamam","year":"2014","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.exer.2025.110273_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.34133\/research.0291","article-title":"AAV for gene therapy in ocular diseases : progress and prospects","volume":"6","author":"He","year":"2023","journal-title":"Research"},{"issue":"10089","key":"10.1016\/j.exer.2025.110273_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(17)30979-0","article-title":"Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration : a phase 1, open-label trial","volume":"390","author":"Heier","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.exer.2025.110273_bib28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV serotypes and their applications in gene therapy : an overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.exer.2025.110273_bib29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2025.110273_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.740057","article-title":"TNF-\u0391 in uveitis : from bench to clinic","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2025.110273_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.omtm.2020.03.018","article-title":"Peripapillary intravitreal injection improves AAV-mediated retinal transduction","volume":"17","author":"Madrakhimov","year":"2020","journal-title":"Mole. Therap. Method Clinical Develop."},{"issue":"9","key":"10.1016\/j.exer.2025.110273_bib32","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation\u2013associated inherited retinal dystrophy","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.exer.2025.110273_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current clinical applications of in vivo gene therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.exer.2025.110273_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"issue":"4","key":"10.1016\/j.exer.2025.110273_bib35","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013392","article-title":"Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders","volume":"13","author":"Pavlou","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.exer.2025.110273_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109237","article-title":"Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection","volume":"224","author":"Puranen","year":"2022","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2025.110273_bib37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/hum.2016.111","article-title":"Evaluation of dose and safety of AAV7m8 and AAV8BP2 in the non-human primate retina","volume":"28","author":"Ramachandran","year":"2017","journal-title":"Hum. Gene Ther."},{"issue":"12","key":"10.1016\/j.exer.2025.110273_bib38","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/jcm8122082","article-title":"AAV mediated delivery of myxoma virus M013 gene protects the retina against autoimmune uveitis","volume":"8","author":"Ridley","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.exer.2025.110273_bib39","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1167\/iovs.02-1156","article-title":"Neutralizing tumor necrosis factor-\u03b1 activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis","volume":"44","author":"Robertson","year":"2003","journal-title":"Investig. Opthalmol. Visual Sci."},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib40","first-page":"1","article-title":"Adeno-associated virus infection and its impact in human health : an overview","volume":"19","author":"Sant'Anna","year":"2022","journal-title":"Virol. J."},{"issue":"7","key":"10.1016\/j.exer.2025.110273_bib41","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study : visual III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.exer.2025.110273_bib42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ophtha.2020.10.036","article-title":"Long-term safety and efficacy of adalimumab in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis","volume":"128","author":"Suhler","year":"2021","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.exer.2025.110273_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000819","article-title":"Adalimumab in patients with vision-threatening uveitis : real-world clinical experience","volume":"6","author":"Tang Lee Say","year":"2021","journal-title":"BMJ Open Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2025.110273_bib44","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/emmm.201302948","article-title":"Effective delivery of large genes to the retina by dual AAV vectors","volume":"6","author":"Trapani","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"9","key":"10.1016\/j.exer.2025.110273_bib45","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.4103\/ijo.IJO_1548_20","article-title":"Systemic immunosuppressive therapies for uveitis in developing countries","volume":"68","author":"Tyagi","year":"2020","journal-title":"Indian J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2025.110273_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061396","article-title":"AAV-mediated gene therapy for choroideremia : preclinical studies in personalized models","volume":"8","author":"Vasireddy","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.exer.2025.110273_bib47","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10238-022-00954-6","article-title":"Pathogenesis and current therapies for non-infectious uveitis","volume":"23","author":"Wu","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"21","key":"10.1016\/j.exer.2025.110273_bib48","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/CM9.0000000000001015","article-title":"Blood-retinal barrier as a converging pivot in understanding the initiation and development of retinal diseases","volume":"133","author":"Yang","year":"2020","journal-title":"Chin. Med J"},{"key":"10.1016\/j.exer.2025.110273_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.omtm.2021.06.005","article-title":"Pre-retinal delivery of recombinant adeno-associated virus vector significantly improves retinal transduction efficiency","volume":"22","author":"Zhang","year":"2021","journal-title":"Mole. Therap. Method Clinical Develop."},{"issue":"3","key":"10.1016\/j.exer.2025.110273_bib50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ymthe.2005.04.004","article-title":"Activation of the extracellular signal-regulated kinase 1\/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma","volume":"12","author":"Zhou","year":"2005","journal-title":"Mol. Ther."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:35:07Z","timestamp":1777412107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"alternative-id":["S0014483525000442"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110273","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant adeno-associated virus with anti-tumor necrosis factor-alpha in an experimental autoimmune uveitis model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110273"}}